RPE65 and Leber congenital amaurosis: Gene identification, proof-of-concept and safety studies in animals, and detailed human studies of photoreceptor layer integrity have led to treatment trials in the molecular form of LCA caused by mutations in RPE65, the gene encoding retinal pigment epithelium-specific protein, 65 kDa [3-10].